Work

Abstract 4932: Excision repair cross-complementing group-1 (ERCC1) induction and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2019-4932

Authors: Devika Rao, Atrayee Basu Mallick, Titto Augustine, Cecilia Daroqui, Jeeshan Jiffry, Amartej Merla, Imran Chaudhary, Raviraja Seetharaman, Arjun Sood, Srikanth Gajavelli, Santiago Aparo, Lakshmi Rajdev, Andreas Kaubisch, Jennifer Chuy, Radhashree Maitra, Sanjay Goel

Institutions: Albert Einstein College of Medicine, Montefiore Einstein Comprehensive Cancer Center, Thomas Jefferson University, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de Córdoba, Bristol-Myers Squibb (United States), Baptist Health South Florida

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4251686875

Cites:

Cited by:

Related to: 10